{"id":167,"date":"2024-09-24T16:49:36","date_gmt":"2024-09-24T20:49:36","guid":{"rendered":"https:\/\/sites.bu.edu\/kolab\/?page_id=167"},"modified":"2024-09-25T15:58:56","modified_gmt":"2024-09-25T19:58:56","slug":"publications","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/kolab\/research\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"
2024<\/h5>\n
    \n
  1. \n
    Beaulieu-Jones BR, Ha EJ, Fefferman A, Wang J, Chung SH, Tseng JF, Merrill A, Sachs TE, Ko NY, Cassidy MR. ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann Surg Oncol. 2024 Jul 03.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>38961042<\/a><\/span><\/div>\n<\/li>\n
  2. \n
    Qiu Y, Chen A, Yu R, Llevenes P, Seen M, Ko NY, Monti S, Denis GV. Insulin Resistance Increases TNBC Aggressiveness and Brain Metastasis via Adipocyte-derived Exosomes. bioRxiv. 2024 May 02.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>38746141<\/a>; PMCID:\u00a0<\/span>PMC11092600<\/a>; DOI:\u00a0<\/span>10.1101\/2024.05.01.592097<\/a>;<\/span><\/div>\n<\/li>\n
  3. \n
    Mayer EL, Ren Y, Wagle N, Mahtani R, Ma C, DeMichele A, Cristofanilli M, Meisel J, Miller KD, Abdou Y, Riley EC, Qamar R, Sharma P, Reid S, Sinclair N, Faggen M, Block CC, Ko N, Partridge AH, Chen WY, DeMeo M, Attaya V, Okpoebo A, Alberti J, Liu Y, Gauthier E, Burstein HJ, Regan MM, Tolaney SM. PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4\/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive\/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. J Clin Oncol. 2024 Jun 10; 42(17):2050-2060. PMID:\u00a0<\/span>38513188<\/a><\/span><\/div>\n<\/li>\n
  4. \n
    Beaulieu-Jones BR, Ha EJ, Fefferman A, Wang J, Chung SH, Tseng JF, Merrill A, Sachs TE, Ko NY, Cassidy MR. Association of Race, Ethnicity, Language, and Insurance with Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann Surg Oncol. 2024 Mar; 31(3):1608-1614.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>38017122<\/a><\/span><\/div>\n<\/li>\n
  5. \n
    Huang HC, Guadamuz JS, Hoskins KF, Ko NY, Calip GS. Risk of contralateral breast cancer among Asian\/Pacific Islander women in the United States. Breast Cancer Res Treat. 2024 Feb; 203(3):533-542. PMID:\u00a0<\/span>37897647<\/a><\/span><\/div>\n<\/li>\n<\/ol>\n
    2023<\/h5>\n
      \n
    1. \n
      Ko NY, Fikre TG, Buck AK, Restrepo E, Warner ET. Breast cancer survivorship experiences among Black women. Cancer. 2023 Sep; 129(S19):3087-3101. PMID:\u00a0<\/span>37691522<\/a><\/span><\/div>\n<\/li>\n
    2. \n
      Chung SH, de Geus SWL, Shewmaker G, Romatoski KS, Drake FT, Ko NY, Merrill AL, Hirsch AE, Tseng JF, Sachs TE, Cassidy MR. ASO Visual Abstract: Axillary Lymph Node Dissection is Associated with Improved Survival for Men with Invasive Breast Cancer and Sentinel Node Metastasis. Ann Surg Oncol. 2023 Sep; 30(9):5621-5622.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>37202569<\/a><\/span><\/div>\n<\/li>\n
    3. \n
      Fefferman A, Beaulieu-Jones BR, Shewmaker G, Zhang T, Sachs T, Merrill A, Ko NY, Cassidy MR. Association of Race, Ethnicity, Insurance, and Language and Rate of Breast-Conserving Therapy Among Women With Nonmetastatic Breast Cancer at an Urban, Safety-Net Hospital. J Surg Res. 2023 Nov; 291:403-413.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>37517348<\/a><\/span><\/div>\n<\/li>\n
    4. \n
      Chung SH, de Geus SWL, Shewmaker G, Romatoski KS, Drake FT, Ko NY, Merrill AL, Hirsch AE, Tseng JF, Sachs TE, Cassidy MR. Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis. Ann Surg Oncol. 2023 Sep; 30(9):5610-5618.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>37204557<\/a><\/span><\/div>\n<\/li>\n
    5. \n
      Odai-Afotey A, Lederman RI, Ko NY, Gagnon H, Fikre T, Gundersen DA, Revette AC, Hershman DL, Crew KD, Keating NL, Freedman RA. Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Res Treat. 2023 Jul; 200(1):127-137. PMID:\u00a0<\/span>37178432<\/a>; PMCID:\u00a0<\/span>PMC10182756<\/a>; DOI:\u00a0<\/span>10.1007\/s10549-023-06960-w<\/a><\/span><\/span><\/div>\n<\/li>\n
    6. \n
      Beaulieu-Jones BR, Shewmaker G, Fefferman A, Kenzik K, Zhang T, Drake FT, Sachs TE, Hirsch AE, Merrill A, Ko NY, Cassidy MR. Mitigating disparities in breast cancer treatment at an academic safety-net hospital. Breast Cancer Res Treat. 2023 Apr; 198(3):597-606.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>36826701<\/a><\/span><\/span><\/div>\n<\/li>\n
    7. \n
      Beaulieu-Jones BR, Fefferman A, Woods AP, Shewmaker G, Zhang T, Roh DS, Sachs TE, Merrill A, Ko NY, Cassidy MR. Impact of Race, Ethnicity, Primary Language, and Insurance on Reconstruction after Mastectomy for Patients with Breast Cancer at an Urban, Academic Safety-Net Hospital. J Am Coll Surg. 2023 Jun 01; 236(6):1071-1082.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>36524735<\/a>; DOI:\u00a0<\/span>10.1097\/XCS.0000000000000531<\/a>;<\/span><\/div>\n<\/li>\n
    8. \n
      <\/span>Patel JV, Hughes DM, Ko NY. OPTIMAL Breast Cancer Care: Effect of an Outpatient Pharmacy Team to Improve Management and Adherence to Oral Cancer Treatment. JCO Oncol Pract. 2023 Mar; 19(3):e306-e314.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>36480784<\/a>; DOI:\u00a0<\/span>10.1200\/OP.22.00135<\/a>;<\/span><\/div>\n<\/li>\n<\/ol>\n
      \n
        <\/ol>\n
        2022<\/h5>\n
          \n
        1. Freedman RA, Ko NY, Lederman RI, Gagnon H, Fikre T, Gundersen DA, Revette AC, Odai-Afotey A, Kantor O, Hershman DL, Crew KD, Keating NL. Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Res Treat. 2022 Dec; 196(3):623-633. PMID:\u00a0<\/span>36220997<\/a>; PMCID:\u00a0<\/span>PMC9552717<\/a>; DOI:\u00a0<\/span>10.1007\/s10549-022-06752-8<\/a>;<\/span><\/li>\n
        2. \n
          Choi JJ, Fikre T, Fischman A, Buck AK, Ko NY. The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer Patients. Oncologist. 2022 Oct 01; 27(10):832-838. PMID:\u00a0<\/span>36124631<\/a>; PMCID:\u00a0<\/span>PMC9526492<\/a>; DOI:\u00a0<\/span>10.1093\/oncolo\/oyac132<\/a>;<\/span><\/div>\n<\/li>\n
        3. \n
          Smith CEP, Marcom PK, Mitri Z, Ko NY. Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast Cancer Res Treat. 2022 Nov; 196(1):215-220.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>36087190<\/a>; DOI:\u00a0<\/span>10.1007\/s10549-022-06718-w<\/a>;<\/span><\/div>\n<\/li>\n
        4. \n
          Restrepo E, Ko N, Warner ET. An evaluation of readability and understandability of online education materials for breast cancer survivors. J Cancer Surviv. 2024 Apr; 18(2):457-465. PMID:\u00a0<\/span>35913680<\/a><\/span><\/div>\n<\/li>\n
        5. \n
          Irwin KE, Ko N, Walsh EP, Decker V, Arrillaga-Romany I, Plotkin SR, Franas J, Gorton E, Moy B. Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care. Oncologist. 2022 Jul 05; 27(7):518-524. PMID:\u00a0<\/span>35443045<\/a>; PMCID:\u00a0<\/span>PMC9256021<\/a>; DOI:\u00a0<\/span>10.1093\/oncolo\/oyac069<\/a>;<\/span><\/div>\n<\/li>\n
        6. \n
          Battaglia TA, Gunn CM, Bak SM, Flacks J, Nelson KP, Wang N, Ko NY, Morton SJ. Patient navigation to address sociolegal barriers for patients with cancer: A comparative-effectiveness study. Cancer. 2022 Jul 01; 128 Suppl 13:2623-2635.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>35699610<\/a>; PMCID:\u00a0<\/span>PMC10152516<\/a>; DOI:\u00a0<\/span>10.1002\/cncr.33965<\/a>;<\/span><\/div>\n<\/li>\n
        7. \n
          Huang HC, Smart MH, Zolekar A, Deng H, Hubbard CC, Hoskins KF, Ko NY, Guadamuz JS, Calip GS. Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race\/ethnicity. Breast Cancer Res Treat. 2022 Jun; 193(3):707-716. PMID:\u00a0<\/span>35460499<\/a>; PMCID:\u00a0<\/span>PMC10224670<\/a>; DOI:\u00a0<\/span>10.1007\/s10549-022-06603-6<\/a>;<\/span><\/div>\n<\/li>\n
        8. \n
          Coleman C, Yan CH, Ko NY, Nabulsi NA, Hoskins KF, Chiu BC, Calip GS. Physical functioning, frailty and risks of locally-advanced breast cancer among older women. Breast. 2022 Aug; 64:19-28. PMID:\u00a0<\/span>35468476<\/a>; PMCID:\u00a0<\/span>PMC9039876<\/a>; DOI:\u00a0<\/span>10.1016\/j.breast.2022.04.005<\/a>;<\/span><\/div>\n<\/li>\n
        9. \n
          Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Ko NY, Hoskins KF, Law EH. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes Control. 2022 May; 33(5):793-799. PMID:\u00a0<\/span>35226243<\/a>; PMCID:\u00a0<\/span>PMC9010392<\/a>; DOI:\u00a0<\/span>10.1007\/s10552-022-01561-2<\/a>;<\/span><\/div>\n<\/li>\n
        10. \n
          Mukand NH, Ko NY, Nabulsi NA, Hubbard CC, Chiu BC, Hoskins KF, Calip GS. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Breast Cancer. 2022 Mar; 29(2):287-295. PMID:\u00a0<\/span>34797467<\/a>; PMCID:\u00a0<\/span>PMC8885772<\/a>; DOI:\u00a0<\/span>10.1007\/s12282-021-01309-x<\/a>;<\/span><\/div>\n<\/li>\n
        11. \n
          LeClair AM, Battaglia TA, Casanova NL, Haas JS, Freund KM, Moy B, Parsons SK, Ko NY, Ross J, Ohrenberger E, Mullikin KR, Lemon SC. Assessment of patient navigation programs for breast cancer patients across the city of Boston. Support Care Cancer. 2022 Mar; 30(3):2435-2443.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>34767089<\/a>; PMCID:\u00a0<\/span>PMC8962605<\/a>; DOI:\u00a0<\/span>10.1007\/s00520-021-06675-y<\/a>;<\/span><\/div>\n<\/li>\n<\/ol>\n
          2021<\/h5>\n
            \n
          1. Zhou J, Cueto J, Ko NY, Hoskins KF, Nabulsi NA, Asfaw AA, Hubbard CC, Mitra D, Calip GS, Law EH. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race. Breast. 2021 Oct; 59:367-375. PMID:\u00a0<\/span>34419726<\/a>; PMCID:\u00a0<\/span>PMC8379689<\/a>; DOI:\u00a0<\/span>10.1016\/j.breast.2021.08.005<\/a>;<\/span><\/li>\n
          2. \n
            Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Res Treat. 2021 Oct; 189(3):769-779. PMID:\u00a0<\/span>34241741<\/a><\/span><\/div>\n<\/li>\n
          3. \n
            Zhou J, Sweiss K, Han J, Ko NY, Patel PR, Chiu BC, Calip GS. Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410. PMID:\u00a0<\/span>34313746<\/a>; PMCID:\u00a0<\/span>PMC8316999<\/a>; DOI:\u00a0<\/span>10.1001\/jamanetworkopen.2021.18410<\/a>;<\/span><\/div>\n<\/li>\n
          4. \n
            Spink S, Teng F, Pera V, Peterson H, Cormier T, Sauer-Budge A, Chargin D, Brookfield S, Eggebrecht A, Ko NY, Roblyer D. High optode-density wearable diffuse optical probe for monitoring paced breathing hemodynamics in breast tissue. J Biomed Opt. 2021 06; 26(6).View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>34080400<\/a>; PMCID:\u00a0<\/span>PMC8170390<\/a>; DOI:\u00a0<\/span>10.1117\/1.JBO.26.6.062708<\/a>;<\/span><\/div>\n<\/li>\n
          5. \n
            Hoskins KF, Danciu OC, Ko NY, Calip GS. Association of Race\/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. JAMA Oncol. 2021 03 01; 7(3):370-378. PMID:\u00a0<\/span>33475714<\/a>; PMCID:\u00a0<\/span>PMC7821091<\/a>; DOI:\u00a0<\/span>10.1001\/jamaoncol.2020.7320<\/a>;<\/span><\/div>\n<\/li>\n
          6. \n
            Chen K, Abbassi M, Ko NY. A Shock-Like Pain and Inability to Ambulate: Thoracic Spinal Cord Compression from Hepatocellular Carcinoma. Case Rep Oncol. 2021 Jan-Apr; 14(1):56-61. PMID:\u00a0<\/span>33776682<\/a>; PMCID:\u00a0<\/span>PMC7983535<\/a>; DOI:\u00a0<\/span>10.1159\/000509511<\/a>;<\/span><\/div>\n<\/li>\n
          7. \n
            Zhou J, Sweiss K, Nutescu EA, Han J, Patel PR, Ko NY, Lee TA, Chiu BC, Calip GS. Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncol Pract. 2021 03; 17(3):e294-e312. PMID:\u00a0<\/span>33449809<\/a>; PMCID:\u00a0<\/span>PMC8257921<\/a>; DOI:\u00a0<\/span>10.1200\/OP.20.00479<\/a>;<\/span><\/div>\n<\/li>\n
          8. \n
            Poulson MR, Beaulieu-Jones BR, Kenzik KM, Dechert TA, Ko NY, Sachs TE, Cassidy MR. Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival. Ann Surg. 2021 01 01; 273(1):3-9.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>32889878<\/a><\/span><\/div>\n<\/li>\n
          9. \n
            Gupta VK, Dennis M, Mann E, Jacobson JO, Ko NY. Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital. JCO Oncol Pract. 2021 03; 17(3):e454-e460.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>33290161<\/a><\/span><\/div>\n<\/li>\n<\/ol>\n
            2020<\/h5>\n
              \n
            1. Oladeru OT, Hirsch AE, Ko NY. Trends in Deescalation of Localized Breast Cancer Treatment and Caution for the Most Vulnerable Patients-A Look Back on the Decade That Was. JAMA Oncol. 2020 12 01; 6(12):1863-1864.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>32970115<\/a><\/span><\/li>\n
            2. \n
              Lombardi FL, Jafari N, Bertrand KA, Oshry LJ, Cassidy MR, Ko NY, Denis GV. Novel semi-automated algorithm for high-throughput quantification of adipocyte size in breast adipose tissue, with applications for breast cancer microenvironment. Adipocyte. 2020 12; 9(1):313-325.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>32633194<\/a>; PMCID:\u00a0<\/span>PMC7469507<\/a>; DOI:\u00a0<\/span>10.1080\/21623945.2020.1787582<\/a>;<\/span><\/div>\n<\/li>\n
            3. \n
              Ko NY, Qureshi MM, Oladeru OT, Cassidy MR, Oshry L, Truong MT, Hirsch AE. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020 Dec; 184(3):849-859.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>32888137<\/a><\/span><\/div>\n<\/li>\n
            4. \n
              Mukand NH, Zolekar A, Ko NY, Calip GS. Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2220-2229. PMID:\u00a0<\/span>32856609<\/a>; PMCID:\u00a0<\/span>PMC10772992<\/a>; DOI:\u00a0<\/span>10.1158\/1055-9965.EPI-20-0095<\/a>;<\/span><\/div>\n<\/li>\n
            5. \n
              Ghosh S, Chen ML, Weinberg J, Fikre T, Ko NY. Hepatitis C Virus Infection and Chemotherapy in Breast Cancer: A Retrospective Chart Analysis. Oncologist. 2020 10; 25(10):845-852.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>32488966<\/a>; PMCID:\u00a0<\/span>PMC7543236<\/a>; DOI:\u00a0<\/span>10.1634\/theoncologist.2020-0172<\/a>;<\/span><\/div>\n<\/li>\n
            6. \n
              Festa K, Hirsch AE, Cassidy MR, Oshry L, Quinn K, Sullivan MM, Ko NY. Breast Cancer Treatment Delays at an Urban Safety Net Hospital Among Women Experiencing Homelessness. J Community Health. 2020 06; 45(3):452-457.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>31625050<\/a><\/span><\/div>\n<\/li>\n
            7. \n
              Coleman C, Yan C, Ko NY, Chiu B, Calip GS. PCN181 PHYSICAL FUNCTIONING, FRAILTY AND RISKS OF LOCALLY-ADVANCED BREAST CANCER AMONG OLDER WOMEN. Value in Health. 2020; 23:S55.\u00a0<\/span>View Publication<\/a><\/span><\/div>\n<\/li>\n
            8. \n
              McCormick C, Ko NY, Calip GS. MC3 DISPARITIES IN HEALTH INSURANCE STATUS AMONG YOUNG ADULT CANCER PATIENTS IN STATES WITH AND WITHOUT MEDICAID EXPANSION: ANALYSES OF THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS REGISTRIES, 2007 – 2016. Value in Health. 2020; 23.\u00a0<\/span>View Publication<\/a><\/span><\/div>\n<\/li>\n
            9. \n
              Nabulsi NA, Alobaidi A, Talon B, Asfaw AA, Zhou J, Sharp LK, Sweiss K, Patel PR, Ko NY, Chiu BC, Calip GS. Self-reported health and survival in older patients diagnosed with multiple myeloma. Cancer Causes Control. 2020 Jul; 31(7):641-650. PMID:\u00a0<\/span>32356139<\/a>; PMCID:\u00a0<\/span>PMC7274896<\/a>; DOI:\u00a0<\/span>10.1007\/s10552-020-01305-0<\/a>;<\/span><\/div>\n<\/li>\n
            10. \n
              Zhou J, Asfaw AA, Nabulsi NA, Mukand NA, Lee I, Ko NY, Boudreau DM, Calip GS. HSR20-113: Diabetes Complications and Risks of Breast Cancer Recurrence Among Older Women. Journal of the National Comprehensive Cancer Network. 2020; 18(3.5).\u00a0<\/span>View Publication<\/a><\/span><\/div>\n<\/li>\n
            11. \n
              Tank A, Peterson HM, Pera V, Tabassum S, Leproux A, O’Sullivan T, Jones E, Cabral H, Ko N, Mehta RS, Tromberg BJ, Roblyer D. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens. Breast Cancer Res. 2020 03 13; 22(1):29.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>32169100<\/a>; PMCID:\u00a0<\/span>PMC7071774<\/a>; DOI:\u00a0<\/span>10.1186\/s13058-020-01262-1<\/a>;<\/span><\/div>\n<\/li>\n
            12. \n
              Ko NY, Hong S, Winn RA, Calip GS. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer. JAMA Oncol. 2020 03 01; 6(3):385-392. PMID:\u00a0<\/span>31917398<\/a>; PMCID:\u00a0<\/span>PMC6990828<\/a>; DOI:\u00a0<\/span>10.1001\/jamaoncol.2019.5672<\/a>;<\/span><\/div>\n<\/li>\n
            13. \n
              Kim KN, Qureshi MM, Huang D, Ko NY, Cassidy M, Oshry L, Hirsch AE. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis. Clin Breast Cancer. 2020 04; 20(2):e200-e213.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>32089454<\/a><\/span><\/div>\n<\/li>\n
            14. \n
              Alobaidi A, Nabulsi NA, Talon B, Asfaw AA, Zhou J, Sharp LK, Sweiss K, Patel PR, Ko NY, Chiu BC, Calip GS. Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma. Support Care Cancer. 2020 Sep; 28(9):4097-4106. PMID:\u00a0<\/span>31872292<\/a>; PMCID:\u00a0<\/span>PMC7308221<\/a>; DOI:\u00a0<\/span>10.1007\/s00520-019-05246-6<\/a>;<\/span><\/div>\n<\/li>\n
            15. \n
              Kim NE, Conway-Pearson L, Kavanah M, Mendez J, Sachs TF, Drake FT, Ko NY, McAneny D, Cassidy MR. Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation. J Am Coll Surg. 2020 06; 230(6):947-955.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>31809861<\/a><\/span><\/div>\n<\/li>\n<\/ol>\n
              2019<\/h5>\n
                \n
              1. Guadamuz JS, Ozenberger K, Qato DM, Ko NY, Saffore CD, Adimadhyam S, Cha AS, Moran KM, Sweiss K, Patel PR, Chiu BC, Calip GS. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults. Medicine (Baltimore). 2019 Nov; 98(46):e17960. PMID:\u00a0<\/span>31725657<\/a>; PMCID:\u00a0<\/span>PMC6867777<\/a>; DOI:\u00a0<\/span>10.1097\/MD.0000000000017960<\/a>;<\/span><\/li>\n
              2. \n
                Freund KM, Haas JS, Lemon SC, Burns White K, Casanova N, Dominici LS, Erban JK, Freedman RA, James TA, Ko NY, LeClair AM, Moy B, Parsons SK, Battaglia TA. Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study. Cancer. 2019 12 15; 125(24):4532-4540.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>31449680<\/a>; PMCID:\u00a0<\/span>PMC6891116<\/a>; DOI:\u00a0<\/span>10.1002\/cncr.32432<\/a>;<\/span><\/div>\n<\/li>\n
              3. \n
                Ko NY, Bak S, Gunn C, Nelson KP, Bowen D, Flacks J, Morton S, Parker V, Mendez J, Battaglia TA. An Innovation in Patient Navigation: Background, Methods, and Measures. Journal of Oncology Navigation and Survivorship. 2019; 10(6).\u00a0<\/span>View Publication<\/a><\/span><\/div>\n<\/li>\n
              4. \n
                Nwabudike SM, Edwards CV, Akinboro O, Quinn K, Sarosiek S, Ko N. Cyclin-Dependent Kinase 4\/6 Inhibitor (Palbociclib) Induced Aplastic Anemia in a Patient with Metastatic Breast Cancer. Case Rep Hematol. 2018; 2018:9249506.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>30647983<\/a>; PMCID:\u00a0<\/span>PMC6311830<\/a>; DOI:\u00a0<\/span>10.1155\/2018\/9249506<\/a>;<\/span><\/div>\n<\/li>\n
              5. \n
                Calip GS, Moran KM, Sweiss KI, Patel PR, Wu Z, Adimadhyam S, Lee TA, Ko NY, Quigley JG, Chiu BC. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Cancer. 2019 04 01; 125(7):1143-1154. PMID:\u00a0<\/span>30548485<\/a>; PMCID:\u00a0<\/span>PMC6420387<\/a>; DOI:\u00a0<\/span>10.1002\/cncr.31914<\/a>;<\/span><\/div>\n<\/li>\n
              6. \n
                Saffore CD, Ko NY, Holmes HM, Patel PR, Sweiss K, Adimadhyam S, Chiu BC, Calip GS. Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia. J Geriatr Oncol. 2019 05; 10(3):510-513. PMID:\u00a0<\/span>30270197<\/a><\/span><\/div>\n<\/li>\n<\/ol>\n
                2017<\/h5>\n
                  \n
                1. Khanna S, Kim KN, Qureshi MM, Agarwal A, Parikh D, Ko NY, Rand AE, Hirsch AE. Impact of patient demographics, tumor characteristics, and treatment type on treatment delay throughout breast cancer care at a diverse academic medical center. Int J Womens Health. 2017; 9:887-896.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>29255374<\/a>; PMCID:\u00a0<\/span>PMC5723124<\/a>; DOI:\u00a0<\/span>10.2147\/IJWH.S150064<\/a>;<\/span><\/li>\n
                2. \n
                  Gunn CM, Parker VA, Bak SM, Ko N, Nelson KP, Battaglia TA. Social Network Structures of Breast Cancer Patients and the Contributing Role of Patient Navigators. Oncologist. 2017 Aug; 22(8):918-924.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>28559408<\/a>; PMCID:\u00a0<\/span>PMC5553958<\/a>; DOI:\u00a0<\/span>10.1634\/theoncologist.2016-0440<\/a>;<\/span><\/div>\n<\/li>\n
                3. \n
                  Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer. J Oncol Pract. 2017 May; 13(5):e451-e462. PMID:\u00a0<\/span>28287854<\/a>; DOI:\u00a0<\/span>10.1200\/JOP.2016.018317<\/a>;<\/span><\/div>\n<\/li>\n
                4. \n
                  Wanchoo P, Larrison C, Rosenberg C, Ko N, Cantril C, Moeller N, Parikh R, Djordjevic AM. Identifying Educational Needs of the Multidisciplinary Cancer Team in the Treatment of Metastatic Breast Cancer. J Natl Compr Canc Netw. 2017 Feb; 15(2):205-212. PMID:\u00a0<\/span>28188190<\/a><\/span><\/div>\n<\/li>\n
                5. \n
                  Teng F, Cormier T, Sauer-Budge A, Chaudhury R, Pera V, Istfan R, Chargin D, Brookfield S, Ko NY, Roblyer DM. Wearable near-infrared optical probe for continuous monitoring during breast cancer neoadjuvant chemotherapy infusions. J Biomed Opt. 2017 01 01; 22(1):14001.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>28114449<\/a>; PMCID:\u00a0<\/span>PMC5289133<\/a>; DOI:\u00a0<\/span>10.1117\/1.JBO.22.1.014001<\/a>;<\/span><\/div>\n<\/li>\n<\/ol>\n
                  2016<\/h5>\n
                    \n
                  1. Tran A, Sarosiek S, Ko NY. Challenges in the use of immunotherapy in metastatic melanoma. BMJ Case Rep. 2016 Nov 18; 2016.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>27864299<\/a>; PMCID:\u00a0<\/span>PMC5129100<\/a>; DOI:\u00a0<\/span>10.1136\/bcr-2016-216681<\/a>;<\/span><\/li>\n
                  2. \n
                    Strissel KJ, Nicholas DA, Castagne-Charlotin M, Ko N, Denis GV. Correction to “Barriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research”. Clin Med Insights Womens Health. 2016; 9:35.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>27695380<\/a>; PMCID:\u00a0<\/span>PMC5022798<\/a>; DOI:\u00a0<\/span>10.4137\/CMWH.S40655<\/a>;<\/span><\/div>\n<\/li>\n
                  3. \n
                    Battaglia TA, Darnell JS, Ko N, Snyder F, Paskett ED, Wells KJ, Whitley EM, Griggs JJ, Karnad A, Young H, Warren-Mears V, Simon MA, Calhoun E. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat. 2016 Aug; 158(3):523-34.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>27432417<\/a>; PMCID:\u00a0<\/span>PMC5216421<\/a>; DOI:\u00a0<\/span>10.1007\/s10549-016-3887-8<\/a>;<\/span><\/div>\n<\/li>\n
                  4. \n
                    Strissel KJ, Nicholas DA, Castagne-Charlotin M, Ko N, Denis GV. Barriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research. Clin Med Insights Womens Health. 2016; 9(Suppl 1):57-61.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>27441007<\/a>; PMCID:\u00a0<\/span>PMC4946585<\/a>; DOI:\u00a0<\/span>10.4137\/CMWH.S34698<\/a>;<\/span><\/div>\n<\/li>\n
                  5. \n
                    Pulido V, Lee SY, Ko NY. Arriving at the Right Diagnosis in an Era of Precision Medicine. Case Rep Oncol. 2016 May-Aug; 9(2):351-357.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>27752243<\/a>; PMCID:\u00a0<\/span>PMC5057066<\/a>; DOI:\u00a0<\/span>10.1159\/000447351<\/a>;<\/span><\/div>\n<\/li>\n
                  6. \n
                    Ko NY, Battaglia TA, Gupta-Lawrence R, Schiller J, Gunn C, Festa K, Nelson K, Flacks J, Morton SJ, Rosen JE. Burden of socio-legal concerns among vulnerable patients seeking cancer care services at an urban safety-net hospital: a cross-sectional survey. BMC Health Serv Res. 2016 Jun 14; 16:196.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>27296566<\/a>; PMCID:\u00a0<\/span>PMC4906581<\/a>; DOI:\u00a0<\/span>10.1186\/s12913-016-1443-1<\/a>;<\/span><\/div>\n<\/li>\n
                  7. \n
                    Ko NY, Snyder FR, Raich PC, Paskett ED, Dudley DJ, Lee JH, Levine PH, Freund KM. Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program. Cancer. 2016 Sep 01; 122(17):2715-22. PMID:\u00a0<\/span>27227342<\/a>; PMCID:\u00a0<\/span>PMC4992408<\/a>; DOI:\u00a0<\/span>10.1002\/cncr.30109<\/a>;<\/span><\/div>\n<\/li>\n
                  8. \n
                    Walker A, Ko N. Bringing Medicine to the Digital Age via Hackathons and Beyond. J Med Syst. 2016 Apr; 40(4):98. PMID:\u00a0<\/span>26872780<\/a><\/span><\/div>\n<\/li>\n
                  9. \n
                    Solanki PA, Ko NY, Qato DM, Calip GS. Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011. Springerplus. 2016; 5:82. PMID:\u00a0<\/span>26844029<\/a>; PMCID:\u00a0<\/span>PMC4728166<\/a>; DOI:\u00a0<\/span>10.1186\/s40064-016-1726-3<\/a>;<\/span><\/div>\n<\/li>\n
                  10. \n
                    Walker A, Ko NY. Bringing Medicine to the Digital Age via Hackathons and Beyond. J Med Syst. 2016; 4(40):98.<\/span><\/div>\n<\/li>\n<\/ol>\n
                    2012-2015<\/h5>\n
                      \n
                    1. Ko NY, Fu JL, Lane SC, Finn K, Allten S, Vassilakis N, Stober L, Kachnic L, Battaglia TA. Cancer clinical trial enrollment of diverse and underserved patients within an urban safety net hospital. J Community Support Oncol. 2015 Dec; 13(12):429-35.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>26863873<\/a>; DOI:\u00a0<\/span>10.12788\/jcso.0181<\/a>;<\/span><\/li>\n
                    2. \n
                      Calip GS, Law EH, Ko NY. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors. Breast Cancer Res Treat. 2015 Jun; 151(3):687-96. PMID:\u00a0<\/span>26012645<\/a>; PMCID:\u00a0<\/span>PMC4501770<\/a>; DOI:\u00a0<\/span>10.1007\/s10549-015-3439-7<\/a>;<\/span><\/div>\n<\/li>\n
                    3. \n
                      Ko NY, Darnell JS, Calhoun E, Freund KM, Wells KJ, Shapiro CL, Dudley DJ, Patierno SR, Fiscella K, Raich P, Battaglia TA. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program. J Clin Oncol. 2014 Sep 1; 32(25):2758-64.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>25071111<\/a>; PMCID:\u00a0<\/span>PMC4145185<\/a>; DOI:\u00a0<\/span>10.1200\/JCO.2013.53.6037<\/a>;<\/span><\/div>\n<\/li>\n
                    4. \n
                      Crowley MM, McCoy ME, Bak SM, Caron SE, Ko NY, Kachnic LA, Alvis F, Battaglia TA. Challenges in the delivery of quality breast cancer care: initiation of adjuvant hormone therapy at an urban safety net hospital. J Oncol Pract. 2014 Mar; 10(2):e107-12.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>24345397<\/a>; PMCID:\u00a0<\/span>PMC3948707<\/a>; DOI:\u00a0<\/span>10.1200\/JOP.2013.001164<\/a>;<\/span><\/div>\n<\/li>\n
                    5. \n
                      Raj A, Ko N, Battaglia TA, Chabner BA, Moy B. Patient navigation for underserved patients diagnosed with breast cancer. Oncologist. 2012; 17(8):1027-31.View Related Profiles<\/a>.\u00a0<\/span>PMID:\u00a0<\/span>22752069<\/a>; PMCID:\u00a0<\/span>PMC3425520<\/a>; DOI:\u00a0<\/span>10.1634\/theoncologist.2012-0191<\/a>;<\/span><\/div>\n<\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

                      2024 Beaulieu-Jones BR, Ha EJ, Fefferman A, Wang J, Chung SH, Tseng JF, Merrill A, Sachs TE, Ko NY, Cassidy MR. ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann Surg Oncol. 2024 Jul 03.View Related Profiles.\u00a0PMID:\u00a038961042 […]<\/p>\n","protected":false},"author":24069,"featured_media":0,"parent":32,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"page-templates\/no-sidebars.php","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/pages\/167"}],"collection":[{"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/users\/24069"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/comments?post=167"}],"version-history":[{"count":5,"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/pages\/167\/revisions"}],"predecessor-version":[{"id":176,"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/pages\/167\/revisions\/176"}],"up":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/pages\/32"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/kolab\/wp-json\/wp\/v2\/media?parent=167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}